Your browser doesn't support javascript.
loading
Donor methylenetetrahydrofolate reductase genotype is associated with graft-versus-host disease in hematopoietic stem cell transplant patients treated with methotrexate.
Murphy, N; Diviney, M; Szer, J; Bardy, P; Grigg, A; Hoyt, R; King, B; Macgregor, L; Holdsworth, R; McCluskey, J; Tait, B D.
Affiliation
  • Murphy N; Victorian Transplantation and Immunogenetics Service, Australian Red Cross Blood Service, Melbourne, Australia.
Bone Marrow Transplant ; 37(8): 773-9, 2006 Apr.
Article in En | MEDLINE | ID: mdl-16518429
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Tissue Donors / Methotrexate / Hematopoietic Stem Cell Transplantation / Methylenetetrahydrofolate Reductase (NADPH2) / Genotype Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2006 Document type: Article Affiliation country: Australia Country of publication: United kingdom
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Tissue Donors / Methotrexate / Hematopoietic Stem Cell Transplantation / Methylenetetrahydrofolate Reductase (NADPH2) / Genotype Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2006 Document type: Article Affiliation country: Australia Country of publication: United kingdom